HLB Therapeutics Revenue

In the year 2025, HLB Therapeutics had annual revenue of 69.56B KRW with 26.63% growth. HLB Therapeutics had revenue of 22.78B in the quarter ending December 31, 2025, with 38.36% growth.

Revenue

69.56B

Revenue Growth

+26.63%

P/S Ratio

4.21

Revenue / Employee

1.42B

Employees

Market Cap

292.68B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	69.56B	14.63B	26.63%
Dec 31, 2024	54.93B	2.34B	4.45%
Dec 31, 2023	52.59B	10.19B	24.03%
Dec 31, 2022	42.40B	-1.18B	-2.72%
Dec 31, 2021	43.59B	656.63M	1.53%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
EASY BIO,Inc.	476.94B
Bioneer	330.11B
BINEX	168.47B
GC Cell	165.52B
JETEMA,	76.90B
Anterogen.Co.,Ltd.	7.54B
Genexine	5.81B
MedPacto	3.90B

Revenue Rankings